Scientists have developed an AI platform called CenSegNet to analyse centrosomes, the tiny structures that drive cancer progression but are difficult to study. By identifying two distinct types of abnormalities within tumour samples, this technology could help doctors better predict how the disease develops and support more personalised treatment plans.